Allena Pharmaceuticals, Inc.

OTCPK:ALNA.Q Stock Report

Market Cap: US$109.9k

Allena Pharmaceuticals Valuation

Is ALNA.Q undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALNA.Q when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ALNA.Q's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ALNA.Q's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALNA.Q?

Key metric: As ALNA.Q is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for ALNA.Q. This is calculated by dividing ALNA.Q's market cap by their current book value.
What is ALNA.Q's PB Ratio?
PB Ratio0.03x
BookUS$3.74m
Market CapUS$109.87k

Price to Book Ratio vs Peers

How does ALNA.Q's PB Ratio compare to its peers?

The above table shows the PB ratio for ALNA.Q vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average0.2x
IPIX Innovation Pharmaceuticals
0.2xn/aUS$105.8k
HSTO.Q Histogen
0.02xn/aUS$85.4k
NEXI NexImmune
0.6xn/aUS$418.4k
TCBP TC Biopharm (Holdings)
0.1xn/aUS$359.5k
ALNA.Q Allena Pharmaceuticals
0.03xn/aUS$109.9k

Price-To-Book vs Peers: ALNA.Q is good value based on its Price-To-Book Ratio (0x) compared to the peer average (0.1x).


Price to Book Ratio vs Industry

How does ALNA.Q's PB Ratio compare vs other companies in the US Biotechs Industry?

59 CompaniesPrice / BookEstimated GrowthMarket Cap
Industry Avg.1.9x28.3%
ALNA.Q Allena Pharmaceuticals
0.03xn/aUS$109.87k
GRAL GRAIL
0.2x35.7%US$594.06m
AMRN Amarin
0.4x-7.7%US$217.60m
ALNA.Q 0.0xIndustry Avg. 1.9xNo. of Companies78PB01.63.24.86.48+
59 CompaniesEstimated GrowthMarket Cap
Industry Avg.1.9x28.3%
ALNA.Q Allena Pharmaceuticals
0.03xn/aUS$109.87k
No more companies

Price-To-Book vs Industry: ALNA.Q is good value based on its Price-To-Book Ratio (0x) compared to the US Biotechs industry average (1.6x).


Price to Book Ratio vs Fair Ratio

What is ALNA.Q's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALNA.Q PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.03x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate ALNA.Q's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies